OTCMKTS:CLPBY Coloplast A/S Earnings Date & Estimates $6.60 +0.14 (+2.17%) As of 10/9/2026 03:59 PM Eastern Coloplast A/S is expected to report earnings on Tuesday, November 3, 2026, before market opens. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement Announcement DateNovember 3, 2026TimeBefore Market Opens Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Coloplast A/SColoplast A/S is expected to post earnings of $0.0883 per share on revenue of $1.13 billion. In the same quarter a year earlier Coloplast A/S reported $0.07 per share on revenue of $1.07 billion. Coloplast A/S last reported on August 18, 2026, posting $0.10 per share and matching the $0.10 consensus estimate. Coloplast A/S has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.0883Expected Revenue$1.13 billionPrior-Year EPS$0.07Prior-Year Revenue$1.07 billionExpected EPS Growth+26.2%Expected Revenue Growth+5.0%Recent Track RecordLast ReportedQ3 2026Last Quarter EPS$0.10 (Met Expectations)Last Quarter Revenue$1.14 billionEPS Beat Rate2 of last 8 quartersPrepare for the Earnings CallEarnings HistoryCompany ProfileQ3 2026 Earnings ReportQ2 2026 Earnings ReportQ1 2026 Earnings Report Coloplast A/S Earnings FAQ When does Coloplast A/S report earnings? Coloplast A/S (OTCMKTS:CLPBY) is estimated to report earnings on Tuesday, November 3, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Coloplast A/S? Analysts expect Coloplast A/S to post earnings of $0.0883 per share for the quarter. How much revenue is Coloplast A/S expected to report? The consensus revenue estimate for Coloplast A/S is $1.13 billion for the quarter. Coloplast A/S Earnings HeadlinesHead to Head Analysis: Elutia (NASDAQ:ELUT) and Coloplast A/S (OTCMKTS:CLPBY)October 5, 2026 | americanbankingnews.comCLPBY Share News TodayJune 22, 2026 | uk.investing.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.October 10 at 1:00 AM | Weiss Ratings (Ad)Coloplast's Next Generation Inflatable Penile Prosthesis Approved by the FDA – can help millions of menJune 3, 2026 | globenewswire.comColoplast: Went 'BUY' A Bit EarlyMay 16, 2026 | seekingalpha.comColoplast: The Market Is Throwing Away A High-Quality CompounderMarch 17, 2026 | seekingalpha.comSee More Coloplast A/S Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Coloplast A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coloplast A/S and other key companies, straight to your email. Email Address About Coloplast A/SColoplast A/S (OTCMKTS:CLPBY) is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology. The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management. Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy. The company was established in 1957 by Aage Louis-Hansen and his wife, Johanne Louis-Hansen. Headquartered in Humlebæk, Denmark, Coloplast serves healthcare professionals and patients in markets across Europe, North America, and other international regions. Kristian Villumsen has served as the company’s president and chief executive officer.View Coloplast A/S ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
